Home Business Life Science

Life Science

CMR Surgical appoints Ingeborg Øie as chief financial officer

Company developing Versius surgical robot is continuing its growth

MedImmune brand retired as its work is integrated into AstraZeneca

MedImmune name and logo will no longer be used but "proud legacy of scientific innovation remains", says company

BioStrata recruits five as it continues growth

Histon-based life science communications company is also continuing to recruit

Progress for AstraZeneca and MedImmune on drug for children infected with respiratory virus

The antibody therapy has made progress with both the US Food and Drug Administration and European Medicines Agency

SBRI cultivates two medtech firms with respiratory products

Asthma care boost from organisations nurtured by Milton-based healthcare organisation

Abcam acquires California-based Calico Biolabs

Deal expands the Cambridge life science firm's custom capabilities

AstraZeneca's new Cambridge HQ will be a 'phenomenal' place to work says Dr Mene Pangalos

'Open, porous, collaborative' place will help bolster UK life sciences, says senior executive

£1.1m funding helps CamBioScience turn e-learning into AI-learning

An interview with CEO Dr Chibeza Agley as Cambridge company secures investment for its OBRIZUM platform

A first look inside AstraZeneca's new £500m-plus global HQ and R&D centre on Cambridge Biomedical Campus

We tour the striking building that could redefine what a pharma business looks like

Expedeon becomes a preferred supplier for Babraham-based Cell Guidance Systems

Companies sign agreement for Lightning-Link Rapid Biotin technology

Sosei Heptares receives $15m for cancer therapy milestone

Next-generation immuno-oncology candidate triggers AstraZeneca payment

How AstraZeneca achieved a fivefold increase in its new medicines success rate

Dr Mene Panaglos explains how a change in culture led to dramatic results for the pharmaceutical company

Abcam expects double digit revenue growth

Company says it is preparing for no-deal Brexit

AstraZeneca announces changes as world-renowned cancer expert joins

CEO Pascal Soriot says company expects 'sustained growth' period as new R&D units and commercial units created

PetaGene secures $2.1m after deal with big pharma

Genomics data compression firm was spun out of university in 2016

Chief scientist at AstraZeneca tells of huge potential of partnership with Cancer Research UK

The biopharmaceutical company is teaming up with CRUK on a Functional Genomics Centre in Cambridge

Life Science

AstraZeneca CEO Pascal Soriot says 2018 results herald a new era of sustained growth

CMR Surgical appoints Ingeborg Øie as chief financial officer

CMR Surgical appoints Ingeborg Øie as chief financial officer

MedImmune brand retired as its work is integrated into AstraZeneca

MedImmune brand retired as its work is integrated into AstraZeneca

BioStrata recruits five as it continues growth

BioStrata recruits five as it continues growth

Progress for AstraZeneca and MedImmune on drug for children infected with respiratory virus

Progress for AstraZeneca and MedImmune on drug for children infected with respiratory virus

SBRI cultivates two medtech firms with respiratory products

SBRI cultivates two medtech firms with respiratory products

Abcam acquires California-based Calico Biolabs

Abcam acquires California-based Calico Biolabs

AstraZeneca's new Cambridge HQ will be a 'phenomenal' place to work says Dr Mene Pangalos

AstraZeneca's new Cambridge HQ will be a 'phenomenal' place to work says Dr Mene Pangalos

£1.1m funding helps CamBioScience turn e-learning into AI-learning

£1.1m funding helps CamBioScience turn e-learning into AI-learning

A first look inside AstraZeneca's new £500m-plus global HQ and R&D centre on Cambridge Biomedical Campus

A first look inside AstraZeneca's new £500m-plus global HQ and R&D centre on Cambridge Biomedical Campus

Expedeon becomes a preferred supplier for Babraham-based Cell Guidance Systems

Expedeon becomes a preferred supplier for Babraham-based Cell Guidance Systems

Sosei Heptares receives $15m for cancer therapy milestone

Sosei Heptares receives $15m for cancer therapy milestone

How AstraZeneca achieved a fivefold increase in its new medicines success rate

How AstraZeneca achieved a fivefold increase in its new medicines success rate

Abcam expects double digit revenue growth

Abcam expects double digit revenue growth

AstraZeneca announces changes as world-renowned cancer expert joins

AstraZeneca announces changes as world-renowned cancer expert joins

PetaGene secures $2.1m after deal with big pharma

PetaGene secures $2.1m after deal with big pharma

Chief scientist at AstraZeneca tells of huge potential of partnership with Cancer Research UK

Chief scientist at AstraZeneca tells of huge potential of partnership with Cancer Research UK

MOST READ